|
Symbol |
Object Name |
Qualifiers
|
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G
|
Ache
|
acetylcholinesterase
|
increases activity multiple interactions
|
EXP
|
Alloxan results in increased activity of ACHE protein higenamine inhibits the reaction [Alloxan results in increased activity of ACHE protein]; nuciferine inhibits the reaction [Alloxan results in increased activity of ACHE protein]
|
CTD |
PMID:36297317 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions increases activity
|
EXP
|
Chromium inhibits the reaction [Alloxan results in increased activity of ACOX1 protein]; chromium tripicolinate inhibits the reaction [Alloxan results in increased activity of ACOX1 protein]
|
CTD |
PMID:19693677 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
|
|
G
|
Actb
|
actin, beta
|
decreases expression
|
ISO
|
Alloxan results in decreased expression of ACTB mRNA
|
CTD |
PMID:12137914 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
EXP
|
[Alloxan co-treated with Niacinamide] affects the expression of ADIPOQ protein
|
CTD |
PMID:26429928 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases phosphorylation multiple interactions
|
ISO EXP
|
Alloxan results in decreased phosphorylation of AKT1 protein Phycocyanin inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:26827782 PMID:33359794 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
decreases expression multiple interactions increases expression
|
EXP
|
Alloxan results in decreased expression of APAF1 protein Taurine inhibits the reaction [Alloxan results in increased expression of APAF1 protein]
|
CTD |
PMID:21982801 PMID:23092809 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
|
|
G
|
Atp2a1
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
|
multiple interactions decreases expression
|
EXP
|
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of ATP2A1 protein]
|
CTD |
PMID:28483572 |
|
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:181,026,608...181,044,838
|
|
G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
decreases expression
|
EXP
|
Alloxan results in decreased expression of ATP2A2 protein
|
CTD |
PMID:28483572 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
|
|
G
|
Bad
|
BCL2-associated agonist of cell death
|
increases expression multiple interactions
|
EXP
|
Alloxan results in increased expression of BAD protein Taurine inhibits the reaction [Alloxan results in increased expression of BAD protein]
|
CTD |
PMID:22138235 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP
|
Taurine inhibits the reaction [Alloxan results in increased expression of BAX protein]
|
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
EXP
|
Alloxan results in decreased expression of BCL2 protein Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein]
|
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression multiple interactions
|
EXP
|
Alloxan results in decreased expression of BCL2L1 protein Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2L1 protein]
|
CTD |
PMID:22138235 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases activity increases expression
|
EXP
|
D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP3 protein]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP3 protein modified form]
|
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp9
|
caspase 9
|
increases activity increases expression multiple interactions
|
EXP
|
Alloxan results in increased activity of CASP9 protein Alloxan results in increased expression of CASP9 protein; Alloxan results in increased expression of CASP9 protein modified form D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP9 protein]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein modified form]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein]
|
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cat
|
catalase
|
multiple interactions decreases expression decreases activity
|
EXP ISO
|
3,4-dihydroxyphenylethanol inhibits the reaction [Alloxan results in decreased expression of CAT protein]; Chromium inhibits the reaction [Alloxan results in decreased activity of CAT protein]; chromium tripicolinate inhibits the reaction [Alloxan results in decreased activity of CAT protein]; D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased activity of CAT protein]; higenamine inhibits the reaction [Alloxan results in decreased activity of CAT protein]; nuciferine inhibits the reaction [Alloxan results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Alloxan results in decreased expression of CAT protein] Plant Oils inhibits the reaction [Alloxan results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Alloxan results in decreased activity of CAT protein]
|
CTD |
PMID:10871429 PMID:19393637 PMID:19693677 PMID:21982801 PMID:24946265 PMID:28419827 PMID:36297317 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of CCL2 protein]]
|
CTD |
PMID:18949387 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
multiple interactions decreases expression
|
EXP
|
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of COX4I1 protein]
|
CTD |
PMID:28483572 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:48,721,199...48,727,921
|
|
G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions affects localization
|
EXP
|
Taurine inhibits the reaction [Alloxan affects the localization of CYCS protein]
|
CTD |
PMID:22138235 PMID:23092809 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
Alloxan results in increased expression of DDIT3 mRNA; Alloxan results in increased expression of DDIT3 protein
|
CTD |
PMID:30076216 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G
|
Foxp3
|
forkhead box P3
|
decreases expression multiple interactions
|
ISO
|
Alloxan results in decreased expression of FOXP3 protein platycodin D inhibits the reaction [Alloxan results in decreased expression of FOXP3 protein]
|
CTD |
PMID:25887267 |
|
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:14,908,494...14,923,838
|
|
G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
increases activity multiple interactions
|
EXP
|
Alloxan results in increased activity of G6PC1 protein Sodium Selenite inhibits the reaction [Alloxan results in increased activity of G6PC1 protein]
|
CTD |
PMID:25779343 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
|
|
G
|
Gck
|
glucokinase
|
multiple interactions decreases expression
|
ISO EXP
|
Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]; Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCK protein] Alloxan results in decreased expression of GCK mRNA; Alloxan results in decreased expression of GCK protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK protein]
|
CTD |
PMID:12137914 PMID:26827782 PMID:33359794 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
|
|
G
|
Gckr
|
glucokinase regulator
|
decreases expression multiple interactions
|
ISO
|
Alloxan results in decreased expression of GCKR protein Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCKR protein]
|
CTD |
PMID:26827782 |
|
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
decreases expression multiple interactions
|
EXP
|
Alloxan results in decreased expression of GCLC mRNA; Alloxan results in decreased expression of GCLC protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]]
|
CTD |
PMID:33359794 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
|
|
G
|
Gip
|
gastric inhibitory polypeptide
|
increases secretion
|
EXP
|
Alloxan results in increased secretion of GIP protein
|
CTD |
PMID:6753106 |
|
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
[Alloxan results in increased susceptibility to titanium dioxide] which results in increased activity of GPT protein
|
CTD |
PMID:23873220 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions decreases activity
|
EXP
|
D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased activity of GSR protein]
|
CTD |
PMID:21982801 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G
|
Hmox1
|
heme oxygenase 1
|
decreases expression multiple interactions
|
EXP
|
Alloxan results in decreased expression of HMOX1 mRNA; Alloxan results in decreased expression of HMOX1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]]
|
CTD |
PMID:33359794 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
Alloxan results in increased expression of HSPA5 mRNA
|
CTD |
PMID:30076216 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of ICAM1 protein]]
|
CTD |
PMID:18949387 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions
|
ISO
|
Alloxan results in decreased expression of and results in decreased secretion of IL10 protein; platycodin D inhibits the reaction [Alloxan results in decreased expression of and results in decreased secretion of IL10 protein]
|
CTD |
PMID:25887267 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
|
|
G
|
Il12b
|
interleukin 12B
|
decreases expression
|
ISO
|
Alloxan results in decreased expression of IL12B protein
|
CTD |
PMID:16249388 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
|
|
G
|
Il17a
|
interleukin 17A
|
multiple interactions
|
ISO
|
Alloxan results in increased expression of and results in increased secretion of IL17A protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL17A protein]
|
CTD |
PMID:25887267 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
Alloxan results in increased expression of and results in increased secretion of IL1B protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL1B protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL1B protein]
|
CTD |
PMID:25887267 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
EXP ISO
|
Taurine inhibits the reaction [Alloxan results in increased expression of IL6 protein] Alloxan results in increased expression of and results in increased secretion of IL6 protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL6 protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL6 protein]
|
CTD |
PMID:22138235 PMID:25887267 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Ins1
|
insulin 1
|
multiple interactions decreases expression decreases secretion
|
ISO EXP
|
Plant Oils inhibits the reaction [Alloxan results in decreased expression of INS1 protein] [Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Sertraline binds to 2-Hydroxypropyl-beta-cyclodextrin] inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]; D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Plant Preparations inhibits the reaction [Alloxan results in decreased secretion of INS1 protein]; Sertraline inhibits the reaction [Alloxan results in decreased expression of INS1 protein]
|
CTD |
PMID:19393637 PMID:21050842 PMID:21982801 PMID:26593071 PMID:27317948 PMID:28419827 PMID:33359794 More...
|
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
|
|
G
|
Insr
|
insulin receptor
|
decreases phosphorylation multiple interactions
|
EXP
|
Alloxan results in decreased phosphorylation of INSR protein Taurine inhibits the reaction [Alloxan results in decreased phosphorylation of INSR protein]
|
CTD |
PMID:22138235 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
|
|
G
|
Irs1
|
insulin receptor substrate 1
|
decreases phosphorylation multiple interactions affects phosphorylation
|
EXP ISO
|
Alloxan results in decreased phosphorylation of IRS1 protein Taurine inhibits the reaction [Alloxan results in decreased phosphorylation of IRS1 protein] Alloxan affects the phosphorylation of IRS1 protein Phycocyanin inhibits the reaction [Alloxan affects the phosphorylation of IRS1 protein]
|
CTD |
PMID:22138235 PMID:26827782 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions
|
EXP
|
Alloxan results in increased phosphorylation of MAPK1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:33359794 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation
|
EXP
|
ginsenoside Rh4 inhibits the reaction [Alloxan results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:33359794 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mfn2
|
mitofusin 2
|
decreases expression multiple interactions
|
EXP
|
Alloxan results in decreased expression of MFN2 protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of MFN2 protein]
|
CTD |
PMID:28483572 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
|
|
G
|
Mpo
|
myeloperoxidase
|
increases activity multiple interactions
|
EXP
|
Alloxan results in increased activity of MPO protein Taurine inhibits the reaction [Alloxan results in increased activity of MPO protein]
|
CTD |
PMID:22138235 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G
|
Ndufa9
|
NADH:ubiquinone oxidoreductase subunit A9
|
multiple interactions decreases expression
|
EXP
|
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of NDUFA9 protein]
|
CTD |
PMID:28483572 |
|
NCBI chr 4:161,345,398...161,374,188
Ensembl chr 4:159,659,242...159,688,018
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
decreases expression affects localization multiple interactions
|
EXP
|
Alloxan results in decreased expression of NFE2L2 mRNA Alloxan affects the localization of NFE2L2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]]
|
CTD |
PMID:33359794 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Nos1
|
nitric oxide synthase 1
|
decreases expression
|
ISO
|
Alloxan results in decreased expression of NOS1 mRNA
|
CTD |
PMID:30076216 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
increases expression
|
ISO
|
Alloxan results in increased expression of NOS2 mRNA
|
CTD |
PMID:30076216 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
decreases expression multiple interactions
|
EXP
|
Alloxan results in decreased expression of NQO1 mRNA; Alloxan results in decreased expression of NQO1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]]
|
CTD |
PMID:33359794 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G
|
Nrf1
|
nuclear respiratory factor 1
|
multiple interactions
|
EXP
|
Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein]
|
CTD |
PMID:28483572 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases degradation multiple interactions
|
EXP
|
Alloxan results in increased degradation of PARP1 protein D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased degradation of PARP1 protein]
|
CTD |
PMID:21982801 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
multiple interactions decreases expression
|
EXP
|
ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of PDX1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of PDX1 protein] Alloxan results in decreased expression of PDX1 mRNA; Alloxan results in decreased expression of PDX1 protein
|
CTD |
PMID:33359794 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions decreases expression
|
EXP
|
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of PPARGC1A protein]
|
CTD |
PMID:28483572 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases expression
|
ISO EXP
|
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]] Alloxan results in increased expression of RELA protein Taurine inhibits the reaction [Alloxan results in increased expression of RELA protein]
|
CTD |
PMID:19020780 PMID:22138235 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G
|
Rorc
|
RAR-related orphan receptor C
|
increases expression multiple interactions
|
ISO
|
Alloxan results in increased expression of RORC protein platycodin D inhibits the reaction [Alloxan results in increased expression of RORC protein]
|
CTD |
PMID:25887267 |
|
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:182,009,286...182,034,907
|
|
G
|
Sdha
|
succinate dehydrogenase complex flavoprotein subunit A
|
multiple interactions decreases expression
|
EXP
|
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of SDHA protein]
|
CTD |
PMID:28483572 |
|
NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:28,940,164...28,961,535
|
|
G
|
Slc2a2
|
solute carrier family 2 member 2
|
decreases expression multiple interactions
|
ISO EXP
|
Alloxan results in decreased expression of SLC2A2 mRNA Glucose inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA] Alloxan results in decreased expression of SLC2A2 mRNA; Alloxan results in decreased expression of SLC2A2 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of SLC2A2 protein]
|
CTD |
PMID:12137914 PMID:33359794 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933
|
|
G
|
Slc2a4
|
solute carrier family 2 member 4
|
affects localization multiple interactions decreases expression
|
EXP ISO
|
Alloxan affects the localization of SLC2A4 protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of SLC2A4 protein]; Taurine inhibits the reaction [Alloxan affects the localization of SLC2A4 protein] Quercetin inhibits the reaction [Alloxan results in decreased expression of SLC2A4 protein]
|
CTD |
PMID:22138235 PMID:24946265 PMID:28483572 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
|
|
G
|
Sod1
|
superoxide dismutase 1
|
affects response to substance multiple interactions decreases activity
|
ISO EXP
|
SOD1 protein affects the susceptibility to Alloxan Sulfur Dioxide inhibits the reaction [Alloxan results in decreased activity of SOD1 protein]
|
CTD |
PMID:10871429 PMID:18502742 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
ISO EXP
|
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]] Taurine inhibits the reaction [Alloxan results in increased expression of TNF protein] Alloxan results in increased expression of and results in increased secretion of TNF protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of TNF protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of TNF protein]
|
CTD |
PMID:19020780 PMID:22138235 PMID:25887267 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Trpm7
|
transient receptor potential cation channel, subfamily M, member 7
|
increases expression
|
ISO
|
Alloxan results in increased expression of TRPM7 mRNA; Alloxan results in increased expression of TRPM7 protein
|
CTD |
PMID:30076216 |
|
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
|
|
G
|
Uqcrc2
|
ubiquinol cytochrome c reductase core protein 2
|
increases expression multiple interactions
|
EXP
|
Alloxan results in increased expression of UQCRC2 protein imisopasem manganese promotes the reaction [Alloxan results in increased expression of UQCRC2 protein]
|
CTD |
PMID:28483572 |
|
NCBI chr 1:184,599,240...184,629,804
Ensembl chr 1:175,167,894...175,199,453
|
|
G
|
Xdh
|
xanthine dehydrogenase
|
increases activity multiple interactions
|
EXP
|
Alloxan results in increased activity of XDH protein Taurine inhibits the reaction [Alloxan results in increased activity of XDH protein]
|
CTD |
PMID:22138235 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
|
|